非常严格控制2型糖尿病血糖是否安全——目标是糖化血红蛋白小于6.5%,但不使用高强度治疗方案
Safety of very tight blood glucose control in type 2 diabetes --Aim for glycated haemoglobin lower than 6.5%, but without using highly intensive treatment
摘要
2008年2月8日,在高危心血管事件发生风险的2型糖尿病患者进行的一项大型随机对照研究(ACCORD),因为安全性问题被提前18个月终止了。高强度降低血糖以期达到较现有指南推荐的目标值更低的治疗目标(糖化血红蛋白(HbAlc)〈6.0%),与降糖力度稍低的标准治疗方案(HbAlc7.0%-7.9%)相比,增加了死亡的风险。这在控制率是10/1000/受试者年的基础上,增加额外死亡3/1000/受试者年。
出处
《英国医学杂志中文版》
2008年第5期262-263,共2页
The BMJ Chinese Edition
参考文献11
-
1National Heart, Lung, and Blood Institute. For safety, NHLBI changes intensive blood sugar treatment strategy in clinical trial of diabetes and cardiovascular disease. 2008. http://public. nhlbi. nih. gov/newsroom/home/ GetPressRelease. aspx? id =2551.
-
2Clinical Guidelines Task Force. Global guideline for the management of type 2 diabetes. Brussels, International Diabetes Federation, 2005. www. idf. org/ home/index. cfm? node = 1457.
-
3Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the tlfiazolldinediones. Diabetologia 2007 ;51:8-11.
-
4UK Prospective Diabetes Study (uKPl)S) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33 ). Lancet 1998:352,837-53.
-
5UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood- glucose control with mefformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.
-
6Riddle M, Rosenstock J, Gerich J ; on behalf of the insulin glargine 4002 study investigators. The treat-to-target trial : randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003 ;26: 3080-6.
-
7Holman RR, Thorne KI, Farmer A J, Davies M J, Keenan JF, Paul S, et al; for the 4-T Study Group. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med 2007;357:1716-30.
-
8ACCORD Trial. ACCORD purpose. 2006. www. aeeordtria. org/public/ index. cfm.
-
9The George Institute for International Health. Major international diabetes study does not confirm increased risk of death reported by US trial. 2008. www. advance-trial. com/static/upload/PDF/Media_release Feb08. pdf.
-
10ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial) : a randomised controlled trial. Lancet 2007 ;370:829-40.
-
1ACCORD降压分支研究结果揭晓[J].药品评价,2010,7(7):38-38.
-
2Gerstein H.C.,Riddle M.C.,Kendall D.M.,马超.ACCORD试验中的血糖治疗方案[J].世界核心医学期刊文摘(心脏病学分册),2007(11):23-24. 被引量:3
-
3苏哲坦.饮酒与心血管疾病和健康[J].心血管病学进展,2002,23(3):170-172. 被引量:9
-
4血脂异常的2型糖尿病患者心血管疾病风险可进一步降低[J].中华内科杂志,2010,49(6):468-468.
-
5KatherineM.Flegal,PhD Barry I.Graubard,PhD David F.Willamson,PhD 顾佳(译).体重不足、超重及肥胖所致各类疾病的额外死亡[J].美国医学会杂志(中文版),2008,27(2):75-75.
-
6郭艺芳.2008年AHA发布急性冠状动脉综合征患者血糖管理共识声明[J].临床荟萃,2010,25(19).
-
7Ben G Armstrong,Punam Mangtani,Astrid Fletcher,Sari Kovats,Anthony McMichael,Sam Pattenden,Paul Wilkinson,胡恩坦.流感疫苗对流感高发期额外死亡的影响:老年人队列研究[J].英国医学杂志中文版,2005,8(1):62-62.
-
8朱大龙.严格糖尿病患者降糖治疗达标个体化[J].糖尿病新世界,2010(6):22-22.
-
9ACCORD调脂分支研究结果揭晓[J].药品评价,2010,7(7):38-38.
-
10哪类吸烟者易发生慢性阻塞性肺疾病?[J].中华全科医师杂志,2010,9(2):111-111.